Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

JOURNAL ARTICLE published 2014 in Vascular Cell

Authors: Yuji Yamamoto | Junji Matsui | Tomohiro Matsushima | Hiroshi Obaishi | Kazuki Miyazaki | Katsuji Nakamura | Osamu Tohyama | Taro Semba | Atsumi Yamaguchi | Sachi Hoshi | Fusayo Mimura | Toru Haneda | Yoshio Fukuda | Jun-ichi Kamata | Keiko Takahashi | Masayuki Matsukura | Toshiaki Wakabayashi | Makoto Asada | Ken-ichi Nomoto | Tatsuo Watanabe | Zoltan Dezso | Kentaro Yoshimatsu | Yasuhiro Funahashi | Akihiko Tsuruoka